You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Claims for Patent: 4,582,807


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,582,807
Title: Cultivation medium for mycobacteria and use thereof
Abstract:A medium for the rapid cultivation of mycobacteria, in particular leprosy and tubercle bacilli, comprises amino acids, sugars, phospholipids, muscle metabolism compounds, vitamins, inorganic salts and trace minerals.
Inventor(s): Veeraraghavan; Natteri (Madras 600090, IN)
Assignee:
Application Number:06/403,827
Patent Claims:1. A medium suitable for the cultivation of mycobacteria consisting essentially of

(a) from 2 to 2.5 grams per liter of an acidic amino acid selected from the group consisting of aspartic acid, asparagine, glutamic acid and mixtures thereof

(b) a total of 3.4 to 4.1 grams per liter of neutral amino acid selected from the group consisting of .beta.-alanine, DL-.alpha. alanine, phenylalanine, tyrosine, cystine, cysteine, proline, serine, leucine methionine and mixtures thereof

(c) 120-160 mg per liter of arginine

(d) a total of 350-420 mg per liter of "muscle metabolism compound" selected from the group consisting of glycogen, glutathione, adenylic acid, creatine, sarcosine, carnatine, carnosine, glycocyamine, adenosine diphosphate, adenosine triphosphate, phosphocreatin and mixtures thereof

(e) a total of from 1 to 1.5 grams/liter of monosaccharaide sugar selected from the group consisting of glucosamine, mannose, arabinose, galactose, D-ribose and mixtures thereof

(f) from 40-50 mg/liter of adenosine, cytosine or a mixture of the two

(g) a total of from 5 to 10 mg/liter of phospholipid selected from the group consisting of lecithin, phosphotidyl ethanolamine, phosphotidyl inositol, and mixtures thereof

(h) 5-15 mg/liter cholesterol

(i) 0.4-0.6 mg/liter linoleic acid

(j) 1-1.5 mg/liter oleic acid

(k) 4-6 mg/liter histamine

(l) 4-6 mg/liter heparin

(m) a total of 3.5-5 mg/liter of a vitamin selected from the group consisting of vitamins B, D, E, K and mixtures thereof

(n) 4-6 g/liter dextran

(o) 2-3 mg/liter protamine sulfate

(p) 6-10 g/liter inorganic salts and

(q) trace minerals

in sterile water.

2. A medium according to claim 1, wherein the pH is in the range 7.2-7.4.

3. A medium according to claim 1, wherein the acidic amino acids are present in a ratio 4-6:4-6:1 of L-aspartic acid: asparagine: L-glutamic acid.

4. A medium according to claim 1, wherein the amounts of neutral amino acids present are:

.beta.-alanine: 1.35-1.85 g/liter

DL-.alpha. alanine: 0.4-0.6 g/liter

L-proline: 0.08-0.12 g/liter

DL-serine: 0.08-0.12 g/liter

L-leucine: 0.08-0.12 g/liter

phenyl alanine: 0.06-0.08 g/liter

methionine: 0.025-0.035 g/liter

cystine: 0.45-0.5 g/liter

tyrosine: 0.65-0.8 g/liter

cysteine: 0.15-0.25 g/liter.

5. A medium according to any one of claims 1, 2, 3 or 4, which further contains an amino acid selected from the group consisting of L-glycine, .gamma.-aminobutyric acid, taurine, glycylgylcine carnatine and mixtures thereof.

6. A medium according to claims 1, 2, 3 or 4, wherein 95-100% by weight of the said monosaccharide sugar component consists of glucosamine, galactose and arabinose each one of said sugars being present in a substantially equal amount by weight.

7. A medium according to claims 1, 2, 3 or 4, wherein 75-100% of the "muscle metabolism compounds" is a mixture of glycogen and glutathione in a substantially 2:1 weight ratio.

8. A method for cultivating leprosy bacilli which comprises introducing said bacilli into a medium consisting essentially of

(a) from 2 to 2.5 grams per liter of an acidic amino acid selected from the group consisting of aspartic acid, asparagine, glutamic acid and mixtures thereof

(b) a total of 3.5 to 4.1 grams per liter of neutral amino acid selected from the group consisting of .beta.-alanine, DL-.alpha. alanine, pheylalanine, tyrosine, cystine, cysteine, proline, serine, leucine methionine and mixtures thereof

(c) 120-160 mg/per liter of arginine

(d) a total of from 350-420 mg per liter of "muscle metabolism compound" selected from the group consisting of glycogen, glutathione, adenylic acid, creatine, sarcosine, carnatine, carnosine, glycocyamine, adenosine diphosphate, adenosine triphosphate, phosphocreatin and mixtures thereof

(e) a total of from 1 to 1.5 grams liter of monosaccharide sugar selected from the group consisting of glucosamine, mannose, arabinose, galactose, D-ribose and mixtures thereof

(f) from 40-50 mg/liter of adenosine, cytosine or a mixture of the two

(g) a total of 5 to 10 mg/liter of phospholipid selected from the group consisting of lecithin, phosphotidyl ethanolamine, phosphotidyl inositol, and mixtures thereof

(h) 5-15 mg/liter cholesterol

(i) 0.4-0.6 mg/liter linoleic acid

(j) 1-1.5 mg/liter oleic acid

(k) 4-6 mg/liter histamine

(l) 4-6 mg/liter heparin

(m) a total of 3.5-5 mg/liter of a vitamin selected from the group consisting of vitamins B, D, E, K and mixtures thereof

(n) 4-6 g/liter dextran

(o) 2-3 mg/liter protamine sulfate

(p) 6-10 g/liter inorganic salts and

(q) trace minerals

in sterile water and maintaining said medium at a temperature of 0.degree.-10.degree. C.

9. A method for diagnosis leprosy which comprises placing skin scrapings from suspected leper in a medium consisting essentially of

(a) from 2 to 2.5 grams per liter of an acidic amino acid selected from the group consisting of aspartic acid, asparagine glutamic acid and mixtures thereof

(b) a total of from 3.5 to 4.1 grams per liter of neutral amino acid selected from the group consisting of .beta.-alanine, DL-.alpha. alanine, phenylanine, tyrosine, cystine, cysteine, proline, serine, leucine methionine and mixtures thereof

(c) 120-160 mg per liter of arginine

(d) a total of from 350-420 mg per liter of "muscle metabolism compound" selected from the group consisting of glycogen, glutathione, adenylic acid, creatine, sarcosine, carnatine, carnosine, glycocyamine, adenosine diphosphate, adenosine triphosphate, phosphocreatin and mixtures thereof

(e) a total of from 1 to 1.5 grams/liter of monosaccharide sugar selected from the group consisting of glucosamine, mannose, arabinose, galactose, D-ribose and mixtures thereof

(f) from 40-50 mg/liter of adenosine, cytosine or a mixture of the two

(g) a total of from 5 to 10 mg/liter of phospholipid selected from the group consisting of lecithin, phosphotidyl ethanolamine, phosphotidyl inositol and mixtures thereof

(h) 5-15 mg/liter cholesterol

(i) 0.4-0.6 mg/liter linoleic acid

(j) 1-1.5 mg/liter oleic acid

(k) 4-6 mg/liter histamine

(l) 4-6 mg/liter heparin

(m) a total of 3.5-5 mg/liter of a vitamin selected from the group consisting of vitamins B, D, E, K and mixtures thereof

(n) 4-6 g/liter dextran

(o) 2-3 mg/liter protamine sulfate

(p) 6-10 g/liter inorganic salts and

(q) trace minerals

in sterile water and thereafter cultivating the scrpaings in said medium at 0.degree.-10.degree. C. and periodically determining by staining followed by visual observation whether the number of single bacilli present is increasing.

10. A method for testing the sensitivity of leprosy bacillus to a particular drug which comprises cultivating leprosy bacillus in a medium consisting essentially of

(a) from 2 to 2.5 grams per liter of an acidic amino acid selected from the group consisting of aspartic acid, asparagine, glutamic acid and mixtures thereof

(b) a total of from 3.5 to 4.1 grams per liter of neutral amino acid selected from the group consisting of .beta.-alanine, DL-.alpha. alanine, phenylalanine, tyrosine, cystine, cysteine, proline, serine, leucine methionine and mixtures thereof

(c) 120-160 mg per liter of arginine

(d) a total of from 350-420 mg per liter of "muscle metabolism compound" selected from the group consisting of glycogen, glutathione, adenylic acid, creatine, sarcosine, carnatine, carnosine, glycocyamine, adenosine diphosphate, adenosine triphosphate, phosphocreatin and mixtures thereof

(e) a total of from 1 to 1.5 grams/liter of monosaccharide sugar selected from the group consisting of glucosamine, mannose, arabinose, galactose, D-ribose and mixtures thereof

(f) from 40-50 mg/liter of adenosine, cytosine or a mixture of the two

(g) a total of from 5 to 10 mg/liter of phospholipid selected from the group consisting of lecithin, phospotidyl ethanolamine, phosphotidyl inositol, and mixtures thereof

(h) 5-15 mg/liter cholesterol

(i) 0.4-0.6 mg/liter linoleic acid

(j) 1-15 mg/liter oleic acid

(k) 4-6 mg/liter histamine

(l) 4-6 mg/liter heparin

(m) a total of 3.5-5 mg/liter vitamin selected from the group consisting of vitamins B, D, E, K and mixtures thereof

(n) 4-6 g/liter dextran

(o) 2-3 mg/liter portamine sulfate

(p) 6-10 g/liter inorganic salts and

(q) trace minerals

in sterile water in the presence of the test drug and determining by staining followed by visual observation whether the number of single bacilli present is increasing.

11. A method for diagnosing tuberculosis which comprises cultivating a specimen from one suspected of being tubercular in a medium consisting essentially of

(a) from 2 to 2.5 grams per liter of an acidic amino acid selected from the group consisting of aspartic acid, asparagine, glutamic acid and mixtures thereof

(b) a total of from 3.5 to 4.1 grams per liter of neutral amino acid selected from the group consisting of .beta.-alanine, DL-.alpha. alanine, phenylalanine tyrosine, cystine, cysteine, proline, serine, leucine methionine and mixtures thereof

(c) 120-160 mg per liter of arginine

(d) a total of from 350-420 mg per liter of "muscle metabolism compound" selected from the group consisting of glycogen, glutathione, adenylic acid, creatine, sarcosine, carnatine, carnosine, glycocyamine, adenosine diphosphate, adenosine triphosphate, phosphocreatin and mixtures thereof

(e) a total of from 1 to 1.5 grams/liter of monosaccharide sugar selected from the group consisting of glucosamine, mannose, arabinose, galactose, D-ribose and mixtures thereof

(f) from 40-50 mg/liter of adenosine, cytosine or a mixture of the two

(g) a total of from 5 to 10 mg/liter of phospholipid selected from the group consisting of lecithin, phosphotidyl ethanolamine, phosphotidyl inositol and mixtures thereof

(h) 5-15 mg/liter cholesterol

(i) 0.4-0.6 mg/liter linoleic acid

(j) 1-1.5 mg/liter oleic acid

(k) 4-6 mg/liter histamine

(l) 4-6 mg/liter heparin

(m) a total of 3.5-5 mg/liter of a vitamin selected from the group consisting of vitamins B, D, E, K and mixtures thereof

(n) 406 g/liter dextran

(o) 2-3 mg/liter protamine sulfate

(p) 6-10 g/liter inorganic salts and

(q) trace minerals

in sterile water at about 37.degree. C. and periodically determining by staining followed by visual observation whether the number of tubercule bacilli present has increased.

12. A method for testing the sensitivty of tubercule bacilli to a particular drug which comprises cultivating tubercule bacilli in a medium consisting essentially of

(a) from 2 to 2.5 grams per liter of an acidic amino acid selected from the group consisting of aspartic acid, asparagine glutamic acid and mixtures thereof

(b) a total of from 3.5 to 4.1 grams per liter of neutral amino acid selected from the group consisting of .beta.-alanine, DL-.alpha. alanine, phenylalanine, tyrosine, crystine, cysteine, proline, serine, leucine methionine and mixtures thereof

(c) 120-160 mg per liter of arginine

(d) a total of from 350-420 mg per liter of "muscle metabolism compound" selected from the group consisting of glycogen, glutathione, adenylic acid, creatine, sarcosine, carnatine, carnosine, glycocyamine, adenosine diphosphate, adenosine triphosphate phosphocreatin and mixtures thereof

(e) a total of from 1 to 1.5 grams/liter of monosaccharide sugar selected from the group consisting of glucosamine, mannose arabinose, galactose, D-ribose and mixtures thereof

(f) from 40-50 mg/liter of adenosine, cytosine or a mixture of the two

(g) a total of from 5 to 10 mg/liter of phospholipid selected from the group consisting of lecithin, phosphotidyl ethanolamine, phosphotidyl inositol, and mixtures thereof

(h) 5-15 mg/liter cholesterol

(i) 0.4-0.6 mg/liter linoleic acid

(j) 1-1.5 mg/liter oleic acid

(k) 4-6 mg/liter histamine

(l) 4-6 mg/liter heparin

(m) 3.5-5 mg/liter of a vitamin selected from the group consisting of vitamins B, D, E, K and mixtures thereof

(n) 4-6 g/liter dextran

(o) 2-3 mg/liter protamine sulfate

(p) 6-10 g/liter inorganic salts and

(q) trace minerals

in sterile water in the presence of the test drug and periodically determining by staining followed by visual observation whether the number of tubercle bacilli present has increased.

Details for Patent 4,582,807

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Jubilant Hollisterstier Llc N/A positive skin test control-histamine Injection 103891 03/13/1924 ⤷  Try a Trial 2039-09-23
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live For Injection 125123 05/25/2006 ⤷  Try a Trial 2039-09-23
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.